Author:
Mose Stephan,Karapetian Martin,Jüling-Pohlit Lotte,Taborski Brigitte,Ramm Ulla,Damrau Marc,Rahn Angelika,Böttcher Heinz D.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Reference20 articles.
1. Arning M, Blatter J. Gemcitabine in solid tumors ℳ Present status and further development. Onkologie 1997;20:297–304.
2. Eisbruch A, Shewach DS, Urba S, et al. Phase I trial of radiation concurrent with low-dose gemcitabine for head and neck cancer: high mucosal and pharyngeal toxicity. Proc Am Soc Clin Oncol 1997;16:A1377.
3. Fertil B, Dertinger H, Courdi A, et al. Mean inactivation dose: A useful concept for intercomparison of human cell survival curves. Radiat Res 1984;99:73–84.
4. Fleckenstein K, Latz D, Blatter J, et al. Combined effects on ionizing radiation and gemcitabine (GEM) in different cell lines. Eur J Cancer 1997;33:A105.
5. Heinemann V, Schulz L, Issels RD, et al. Gemcitabine: A modulator of intracellular nucleotide and deoxynucleotide metabolism. Semin Oncol 1995;22:11–8.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献